Evidence Hub

Integrated analysis of gut metabolome, microbiome, and exfoliome data in an equine model of intestinal injury

C. Whitfield-Cargile, H. Chung, M. Coleman, N. D. Cohen, A. Chamoun-Emanuelli, I. Ivanov, J. Goldsby, L. Davidson et al.

Microbiome, 2024

10 participants · 10 citations

Abstract

Background The equine gastrointestinal (GI) microbiome has been described in the context of various diseases. The observed changes, however, have not been linked to host function and therefore it remains unclear how specific changes in the microbiome alter cellular and molecular pathways within the GI tract. Further, non-invasive techniques to examine the host gene expression profile of the GI mucosa have been described in horses but not evaluated in response to interventions. Therefore, the objectives of our study were to (1) profile gene expression and metabolomic changes in an equine model of non-steroidal anti-inflammatory drug (NSAID)-induced intestinal inflammation and (2) apply computational data integration methods to examine host-microbiota interactions. Methods Twenty horses were randomly assigned to 1 of 2 groups ( n = 10): control (placebo paste) or NSAID (phenylbutazone 4.4 mg/kg orally once daily for 9 days). Fecal samples were collected on days 0 and 10 and analyzed with respect to microbiota (16S rDNA gene sequencing), metabolomic (untargeted metabolites), and host exfoliated cell transcriptomic (exfoliome) changes. Data were analyzed and integrated using a variety of computational techniques, and underlying regulatory mechanisms were inferred from features that were commonly identified by all computational approaches. Results Phenylbutazone induced alterations in the microbiota, metabolome, and host transcriptome. Data integration identified correlation of…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free